The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Luminor Medical Technologies (TSXV:LMT) recently got featured on CFN Media regarding the company’s partnership with Constance Therapeutics. The companies have agreed to develop and market cannabis-based sexual health products, a large and growing market, starting this year in California. The article describes the California Cannabis market as an extremely profitable one with revenue that is projected to …
Luminor Medical Technologies (TSXV:LMT) recently got featured on CFN Media regarding the company’s partnership with Constance Therapeutics.
The companies have agreed to develop and market cannabis-based sexual health products, a large and growing market, starting this year in California.
The article describes the California Cannabis market as an extremely profitable one with revenue that is projected to reach $3.7 billion in 2018 and rise to $5.1 billion in 2019. The U.S. sexual wellness market alone is projected to reach $8.8 billion by 2025.
“Constance Therapeutics represents an evidence-based process. Her company has been focused on producing scientifically derived cannabis products for the past 10 years — everything that goes through her process is completely vetted. The botanicals that are used are not haphazard; they’ve actually been tested for efficacy and for their ability to work well with cannabis components,” stated the Luminor Science CEO Anton Mattadeen on their recent partnership.
To see the full article, click here.
Click here to connect with Luminor Medical Technologies (TSXV:LMT) for an Investor Presentation
Source: www.cannabisfn.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.